A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial.
Author | |
---|---|
Abstract |
:
This study sought to determine whether uninterrupted apixaban would have similar rates of bleeding and thromboembolic events as does minimally interrupted apixaban at the time of atrial fibrillation (AF) ablation and to compare those results with rates in historical patients treated with uninterrupted warfarin. |
Year of Publication |
:
2018
|
Journal |
:
JACC. Clinical electrophysiology
|
Volume |
:
4
|
Issue |
:
5
|
Number of Pages |
:
580-588
|
ISSN Number |
:
2405-500X
|
URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S2405-500X(17)31089-7
|
DOI |
:
10.1016/j.jacep.2017.11.005
|
Short Title |
:
JACC Clin Electrophysiol
|
Download citation |